Related Experiment Video

Updated: Aug 22, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole

V H Bigley1, R F Duarte, R D Gosling

  • 1Royal Free Hospital, Pond Street, London, UK. vbigley@yahoo.co.uk

Bone Marrow Transplantation
|September 14, 2004
PubMed

Insights

A rare Fusarium dimerum soft-tissue infection in a stem cell transplant patient was successfully treated with voriconazole. This case highlights effective management of invasive mold infections in immunocompromised individuals.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Hematology

Background:

  • Invasive mold infections pose a significant threat to immunocompromised patients, with increasing incidence and antifungal resistance.
  • The management of these infections is evolving with the advent of novel antifungal agents.
  • Stem cell transplant recipients are particularly vulnerable to opportunistic infections.

Observation:

  • A 19-year-old female, 10 days post-allogeneic stem cell transplant for severe aplastic anemia, developed a proven Fusarium dimerum soft-tissue infection of the foot.
  • A concurrent pulmonary infection with the same organism was suspected.
  • The infection persisted despite treatment with AmBisome for a concurrent chest infection.

Findings:

  • This is the first reported case of a proven Fusarium dimerum soft-tissue infection in a stem cell transplant recipient.
  • Successful treatment of the Fusarium dimerum infection was achieved with voriconazole.
  • Voriconazole demonstrated efficacy in managing this challenging fungal infection.

Implications:

  • Voriconazole can be an effective therapeutic option for Fusarium dimerum infections in immunocompromised hosts.
  • This case underscores the importance of prompt diagnosis and targeted antifungal therapy in stem cell transplant recipients.
  • Further research into the management of rare fungal infections in immunocompromised populations is warranted.

More Related Videos

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...